Income affects oncology clinical trial participation

Income affects oncology clinical trial participation
Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials, according to research published online Jan. 7 in the Journal of Clinical Oncology.

(HealthDay)—Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials, according to research published online Jan. 7 in the Journal of Clinical Oncology.

Joseph M. Unger, Ph.C., of the Fred Hutchison Cancer Research Center in Seattle, and colleagues assessed clinical trial participation patterns according to socioeconomic and demographic factors for 5,499 using an Internet-based treatment .

The researchers found that 40 percent of patients discussed clinical trials with their physicians; of these discussions, 45 percent led to offers of clinical trial participation, and about half (51 percent) of these offers led to participation in clinical trials. Overall, the rate of participation in clinical trials was 9 percent. Based on univariate analysis, participation was significantly less likely for older patients and patients with lower income and education. Income remained a significant predictor of clinical trial participation in multivariable analysis (odds ratio, 0.73). For patients aged 65 years and older with universal access to Medicare, lower income still predicted lower participation in trials. Among lower-income patients, cost concerns were more evident.

"Because clinical trials offer the newest cancer treatments, equal access to this important resource for patients of all income groups is essential. Also, improved lower-income participation would allow clinical trials to be conducted more quickly and would better ensure the applicability of trial results to all income levels (i.e., generalizability)," the authors write. "Understanding that income is related to clinical trial participation could help guide aimed at increasing access for lower-income patients."

One author disclosed to NexCura.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Socioeconomic status affects cancer trial referrals

Dec 07, 2012

(HealthDay)—Patients of lower socioeconomic status are less likely to be referred to participate in early-phase cancer trials compared with patients of higher socioeconomic status, according to research ...

Few physicians refer patients to cancer clinical trials

Feb 12, 2011

A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute.

Recommended for you

User comments